Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 1.16 USD 1.75% Market Closed
Market Cap: 21.9m USD
Have any thoughts about
Chemomab Therapeutics Ltd?
Write Note

Wall Street
Price Targets

CMMB Price Targets Summary
Chemomab Therapeutics Ltd

Wall Street analysts forecast CMMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMMB is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 11.55 USD.

Lowest
Price Target
4.04 USD
248% Upside
Average
Price Target
8.16 USD
603% Upside
Highest
Price Target
11.55 USD
896% Upside
Chemomab Therapeutics Ltd Competitors:
Price Targets
GRAL
Grail Inc
28% Downside
KROS
Keros Therapeutics Inc
172% Upside
CSL
CSL Ltd
28% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
61% Upside
688520
Sinocelltech Group Ltd
72% Upside
SVE
Synthaverse SA
42% Upside
GNS
Genus PLC
27% Upside
PYC
PYC Therapeutics Ltd
164% Upside

Revenue
Forecast

Revenue Estimate
Chemomab Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Chemomab Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Chemomab Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CMMB's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for CMMB is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 11.55 USD.

Back to Top